Author

Hui Mei Yang

Silexon AI Technology (China)ORCID 0000-0002-8040-2792Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Chengliang Hu· 1 shared Chunhao YangiD· 1 shared Dan Yang ZhaoiD· 1 shared Enming YuaniD· 1 shared Fang WaniD· 1 shared Fengcai ZhuiD· 1 shared Hainian Zeng· 1 shared Haitao LiiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperSystems Biology

Chengliang Hu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Systems BiologySignal Transduction and Targeted TherapyPeer-reviewedApr 24, 2021

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang…·Jianyang Zeng

This paper presents a data-driven drug repositioning framework that identifies CVL218, a PARP1 inhibitor, as a potential therapeutic for COVID-19 through in silico and experimental validation.

300 citationstop 1%

humanmachine learning (classical)

𝕏 PostBluesky